Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Makoto Isono, Michèle J. Hoffmann, Maria Pinkerneil, et al.
Journal of Experimental & Clinical Cancer Research (2017) Vol. 36, Iss. 1
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet, Robert Montal, Daniela Sia, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 10, pp. 599-616
Open Access | Times Cited: 1632
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Francesca Nazio, Matteo Bordi, Valentina Cianfanelli, et al.
Cell Death and Differentiation (2019) Vol. 26, Iss. 4, pp. 690-702
Open Access | Times Cited: 340
DNA damage checkpoint kinases in cancer
Hannah L. Smith, Harriet Southgate, Deborah A. Tweddle, et al.
Expert Reviews in Molecular Medicine (2020) Vol. 22
Closed Access | Times Cited: 234
Is targeting autophagy mechanism in cancer a good approach? The possible double-edge sword effect
Su Min Lim, Ezanee Azlina Mohamad Hanif, Siok‐Fong Chin
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 110
<p>Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles</p>
Nerea Iturrioz-Rodríguez, Miguel A. Correa‐Duarte, Mónica L. Fanárraga
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 3389-3401
Open Access | Times Cited: 122
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
Lin Ji, Zhongjie Lin, Zhe Wan, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 71
Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines
Alexander Sebastian Hölscher, Wolfgang A. Schulz, Maria Pinkerneil, et al.
Clinical Epigenetics (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 66
Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis
Juntang Yang, Xin Pan, Lan Wang, et al.
Molecular Medicine (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 55
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives
Sen Liu, Xu Chen, Tianxin Lin
Journal of Advanced Research (2021) Vol. 39, pp. 187-202
Open Access | Times Cited: 51
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
J. Koch, Sebastian Johannes Schober, Sruthi V. Hindupur, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Double‐strand DNA break repair: molecular mechanisms and therapeutic targets
Jinpeng Tan, Xingyao Sun, Hongling Zhao, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 22
Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1
Xin Zhang, Karen Man‐Fong Sze, Lo‐Kong Chan, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 37
JNK signaling as a target for anticancer therapy
Kamal S. Abdelrahman, Heba A. Hassan, Salah A. Abdel‐Aziz, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 2, pp. 405-434
Closed Access | Times Cited: 35
Chrysin, The Flavonoid Molecule of Antioxidant Interest
Hamdoon A. Mohammed, Ghassan M. Sulaiman, Salim Albukhaty, et al.
ChemistrySelect (2023) Vol. 8, Iss. 48
Closed Access | Times Cited: 16
DNA Repair Pathway Alterations in Bladder Cancer
Kent W. Mouw
Cancers (2017) Vol. 9, Iss. 4, pp. 28-28
Open Access | Times Cited: 47
RAB3GAP2 dysregulation in adult T-cell leukemia/lymphoma (ATLL) compared to acute lymphoblastic leukemia (ALL): a molecular perspective
Samira Pourrezaei, Arash Letafati, Ghazale Molaverdi, et al.
BMC Research Notes (2025) Vol. 18, Iss. 1
Open Access
An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer
Renjie Luo, Zongtao Zhang, Lingfei Han, et al.
Biomaterials Science (2021) Vol. 9, Iss. 10, pp. 3718-3736
Closed Access | Times Cited: 24
Respiratory Syncytial Virus Enhances SIRT2 Expression Through Wnt/β-Catenin Signaling to Promote Lung Cancer Progression
Wei Cao, Hang Li, Kui Fan, et al.
Jundishapur Journal of Microbiology (2025) Vol. 18, Iss. 5
Open Access
Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target
Jae Hun Jung, Sungyong You, Jaewon Oh, et al.
Cancer Letters (2018) Vol. 437, pp. 1-12
Open Access | Times Cited: 27
Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
Nalini Devarajan, Selvaraj Jayaraman, Senthil Kumar Ganesan
Journal of Cancer Research and Clinical Oncology (2019) Vol. 146, Iss. 1, pp. 1-18
Closed Access | Times Cited: 25
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma
Karine Flem‐Karlsen, Erin McFadden, Nasrin Omar, et al.
Molecular Cancer Therapeutics (2019) Vol. 19, Iss. 3, pp. 895-905
Open Access | Times Cited: 24
FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis
Liwei Lang, Yuanping Xiong, Néstor Prieto‐Domínguez, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 20
Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells
Michèle J. Hoffmann, Sarah Meneceur, Katrin Hommel, et al.
Genes (2021) Vol. 12, Iss. 2, pp. 260-260
Open Access | Times Cited: 18
KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer
Mücahit Varlı, Sung Jin Kim, Myung‐Giun Noh, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Targeting SREBP1 chemosensitizes colorectal cancer cells to gemcitabine by caspase-7 upregulation
Wenlong Shen, Ting Xu, Dong Chen, et al.
Bioengineered (2019) Vol. 10, Iss. 1, pp. 459-468
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top